VISSER et al v. HOFVANDER et al - Page 124




          Interference 103,579                                                        
               We dismiss Visser’s Preliminary Motion No. 5 under 37 CFR              
          § 1.633(c)(4) to have Visser’s Claims 1, 4, 8, 11, 13-20, 22, and           
          24-27 designated as not corresponding to the count (Paper No. 21)           
          (DISMISSED).                                                                
               We dismiss Visser’s contingent Preliminary Motion No. 6                
          (contingent upon denial of Visser’s Preliminary Motions 1-5)                
          under 37 CFR § 1.633(c)(1) to redefine the interfering subject              
          matter by substituting new Count V-1 for Count 1 (Paper No. 22)             
          (DISMISSED).                                                                
               We dismiss Visser’s contingent Preliminary Motion No. 7                
          under 37 CFR § 1.633(f) to be accorded benefit of the                       
          filing dates of Visser’s grandparent application, filed                     
          December 1, 1993, and Visser’s parent application, filed                    
          February 14, 1992, for proposed Count V-1 (Paper No. 23)                    
          (DISMISSED).                                                                
               We dismiss as moot Visser‘s Request To Add Hofvander’s                 
          Patent16 To Interference Pursuant To 37 CFR § 1.642 (Paper                  

               16   U.S. Patent 5,824,798 (Paper No. 141), assigned to                
          Amylogene HB, Svalov, Sweden, naming Anneli Tallberg, Per                   
          Hofvander, Per T. Persson, and Olle Wikstrom as inventors,                  
          issued with the following claims:                                           
                    1.   A process for producing an amylopectin-type                  
               starch comprising:                                                     
                    obtaining a potato tissue which has been transformed by           
               introducing into the genome of the potato tissue a gene                
               construct comprising a promoter and a fragment of the potato           
               gene which codes for the information of granule-bound starch           
               synthase inserted in the anti-sense direction, wherein said            
                                        -124-                                         





Page:  Previous  117  118  119  120  121  122  123  124  125  126  127  128  129  130  131  Next 

Last modified: November 3, 2007